Financials in USD. Standardized financial statements.
A compact view of how Core Scientific, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Revenue? | $502.40M | $640.31M | $544.48M | $60.32M | $59.52M |
| Revenue Growth? | -21.5% | +17.6% | +802.7% | +1.3% | 0.0% |
| Cost of Revenue? | $378.94M | $631.91M | $305.62M | $50.93M | $49.00M |
| Gross Profit? | $123.46M | $8.40M | $238.86M | $9.39M | $10.53M |
| Gross Margin? | +24.6% | +1.3% | +43.9% | +15.6% | +17.7% |
| Operating Expenses? | $108.11M | $252.97M | $72.34M | $21.60M | $23.02M |
| Operating Income? | $8.96M | -$2.11B | $131.49M | -$6.33M | -$11.69M |
| EBITDA? | $114.32M | -$210.56M | $183.84M | $11.95M | -$4.53M |
| Income Before Tax | -$245.80M | -$2.16B | $63.08M | -$12.21M | -$11.92M |
| Income Tax Expense | $683,000 | -$17.09M | $15.76M | $0 | $0 |
| Net Income? | -$246.49M | -$2.15B | $47.31M | -$12.21M | -$11.92M |
| EPS? | $-0.64 | $-6.30 | $0.15 | $-0.04 | $-0.04 |
| Diluted EPS? | $-0.64 | $-6.30 | $0.15 | $-0.04 | $-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality